We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$122B
AUM Growth
+$51B
Cap. Flow
+$46.1B
Cap. Flow %
37.82%
Top 10 Hldgs %
12.48%
Holding
2,601
New
156
Increased
1,070
Reduced
644
Closed
53

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.39B
2
AAPL icon
Apple
AAPL
+$1.66B
3
AMZN icon
Amazon
AMZN
+$1.51B
4
META icon
Meta Platforms (Facebook)
META
+$1.24B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.16B

Top Sells

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$644M
2
CAT icon
Caterpillar
CAT
+$266M
3
DKNG icon
DraftKings
DKNG
+$140M
4
ORCL icon
Oracle
ORCL
+$123M
5
EQR icon
Equity Residential
EQR
+$112M

Sector Composition

Rank Sector Weight
1 Technology 24.17%
2 Healthcare 14.82%
3 Financials 12.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
326
Tandem Diabetes Care
TNDM
$1.17B
$91.9M 0.08%
943,533
+887,777
+1,592% +$79.2M
PH icon
327
Parker-Hannifin
PH
$125B
$91.5M 0.08%
297,879
-9,659
-3% -$2.99M
GS icon
328
Goldman Sachs
GS
$313B
$91.5M 0.08%
240,956
+180,373
+298% +$64.5M
SPB icon
329
Spectrum Brands
SPB
$2.04B
$91.4M 0.08%
1,074,405
-11,839
-1% -$1.04M
INSM icon
330
Insmed
INSM
$23.2B
$90.8M 0.07%
3,189,635
+2,927,018
+1,115% +$86.9M
PBH icon
331
Prestige Consumer Healthcare
PBH
$2.35B
$90M 0.07%
1,727,866
+30,530
+2% +$1.47M
KMPR icon
332
Kemper
KMPR
$1.7B
$90M 0.07%
1,217,480
-3,323
-0.3% -$256K
LIN icon
333
Linde
LIN
$237B
$89.9M 0.07%
310,826
+271,813
+697% +$79.3M
HES
334
DELISTED
Hess
HES
$89.6M 0.07%
1,026,655
+493,772
+93% +$39.9M
CNX icon
335
CNX Resources
CNX
$4.85B
$89.5M 0.07%
6,553,258
+58,077
+0.9% +$812K
VRSK icon
336
Verisk Analytics
VRSK
$26.4B
$89.5M 0.07%
512,155
+508,260
+13,049% +$90.1M
KEX icon
337
Kirby Corp
KEX
$7.95B
$89.2M 0.07%
1,470,997
+201,297
+16% +$13M
RARE icon
338
Ultragenyx Pharmaceutical
RARE
$2.65B
$89M 0.07%
933,677
-91,862
-9% -$9.57M
RGEN icon
339
Repligen
RGEN
$7.44B
$88.8M 0.07%
444,945
+343,025
+337% +$66.5M
ORLY icon
340
O'Reilly Automotive
ORLY
$72.4B
$88.7M 0.07%
2,348,670
+2,316,855
+7,282% +$83.1M
AGNC icon
341
AGNC Investment
AGNC
$12.3B
$88.6M 0.07%
5,243,082
+5,109,569
+3,827% +$90.8M
TTEK icon
342
Tetra Tech
TTEK
$8.23B
$88.5M 0.07%
3,626,475
-140,815
-4% -$3.54M
MTH icon
343
Meritage Homes
MTH
$4.87B
$88.4M 0.07%
1,879,456
+74,374
+4% +$3.75M
T icon
344
AT&T
T
$165B
$87.1M 0.07%
4,007,352
+297,711
+8% +$6.77M
VC icon
345
Visteon
VC
$2.77B
$87M 0.07%
719,781
+718,797
+73,048% +$86.4M
SNAP icon
346
Snap
SNAP
$7.32B
$86.5M 0.07%
1,269,429
+900,290
+244% +$54M
MXL icon
347
MaxLinear
MXL
$6.49B
$86.4M 0.07%
2,033,254
-59,191
-3% -$2.21M
SAN icon
348
Banco Santander
SAN
$194B
$85.6M 0.07%
21,879,970
+81,880
+0.4% +$318K
HMC icon
349
Honda
HMC
$36.5B
$85.1M 0.07%
2,644,414
+9,118
+0.3% +$283K
COF icon
350
Capital One
COF
$124B
$84.9M 0.07%
549,115
+314,758
+134% +$47.5M

Similar funds

Macquarie Group's Q2 2021 Portfolio in Review

As of Q2 2021, Macquarie Group held 2,601 positions worth $122B, up 72% from $70.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group deployed $46.1B of net new capital in Q2 2021, opening 156 new positions and adding to 1,070 existing holdings. Its largest new stake was Canada Goose Holdings: 4,239,426 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Mondelez International, an estimated $644M trimmed.

  • Macquarie Group's largest Q2 2021 buy was Canada Goose Holdings: 4,239,426 shares worth $185M.
  • Macquarie Group added most to Microsoft in Q2 2021, an estimated $2.39B increase.
  • Macquarie Group's biggest Q2 2021 reduction was Mondelez International, cutting an estimated $644M.
  • Macquarie Group fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $60.9M.
  • Macquarie Group's ten largest holdings make up 12% of its $122B portfolio in Q2 2021.
  • Macquarie Group opened 156 new positions and closed 53 in Q2 2021.
  • Macquarie Group's portfolio value rose 72% quarter-over-quarter to $122B.

Based on Macquarie Group's 13F filing for Q2 2021, filed 13 Aug 2021.